BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 27903274)

  • 21. Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIV
    Jia M; Lu H; Kong XP; Cheng-Mayer C; Wu X
    Viruses; 2018 May; 10(5):. PubMed ID: 29772652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection.
    Van Rompay KK; Berardi CJ; Dillard-Telm S; Tarara RP; Canfield DR; Valverde CR; Montefiori DC; Cole KS; Montelaro RC; Miller CJ; Marthas ML
    J Infect Dis; 1998 May; 177(5):1247-59. PubMed ID: 9593009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus.
    Schmitz JE; Kuroda MJ; Santra S; Simon MA; Lifton MA; Lin W; Khunkhun R; Piatak M; Lifson JD; Grosschupff G; Gelman RS; Racz P; Tenner-Racz K; Mansfield KA; Letvin NL; Montefiori DC; Reimann KA
    J Virol; 2003 Feb; 77(3):2165-73. PubMed ID: 12525651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.
    Metzner KJ; Moretto WJ; Donahoe SM; Jin X; Gettie A; Montefiori DC; Marx PA; Binley JM; Nixon DF; Connor RI
    J Gen Virol; 2005 Dec; 86(Pt 12):3375-3384. PubMed ID: 16298985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance.
    Vinton CL; Magaziner SJ; Dowd KA; Robertson SJ; Amaro-Carambot E; Karmele EP; Ortiz AM; Starke CE; Mudd JC; Whitehead SS; Best SM; Pierson TC; Hickman HD; Brenchley JM
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques.
    Wu F; Ourmanov I; Kuwata T; Goeken R; Brown CR; Buckler-White A; Iyengar R; Plishka R; Aoki ST; Hirsch VM
    J Virol; 2012 Aug; 86(16):8835-47. PubMed ID: 22696650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques.
    Schäfer F; Kewenig S; Stolte N; Stahl-Hennig C; Stallmach A; Kaup FJ; Zeitz M; Schneider T
    Gut; 2002 May; 50(5):608-14. PubMed ID: 11950804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simian immunodeficiency virus (SIV)/immunoglobulin G immune complexes in SIV-infected macaques block detection of CD16 but not cytolytic activity of natural killer cells.
    Wei Q; Stallworth JW; Vance PJ; Hoxie JA; Fultz PN
    Clin Vaccine Immunol; 2006 Jul; 13(7):768-78. PubMed ID: 16829614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Cole KS; Alvarez M; Elliott DH; Lam H; Martin E; Chau T; Micken K; Rowles JL; Clements JE; Murphey-Corb M; Montelaro RC; Robinson JE
    Virology; 2001 Nov; 290(1):59-73. PubMed ID: 11883006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralizing antibodies in SIV control: co-impact with T cells.
    Yamamoto H; Matano T
    Vaccine; 2010 May; 28 Suppl 2():B13-7. PubMed ID: 20510737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of intestinal survival surgery on systemic and mucosal immune responses in SIV-infected rhesus macaques.
    Edghill-Smith YY; Aldrich K; Zhao J; Pinczewski J; Kalyanaraman VS; Johnson M; Heyliger A; Perrin RP; Woodward R; Robert-Guroff M
    J Med Primatol; 2002 Dec; 31(6):313-22. PubMed ID: 12519209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.
    Chowdhury A; Hayes TL; Bosinger SE; Lawson BO; Vanderford T; Schmitz JE; Paiardini M; Betts M; Chahroudi A; Estes JD; Silvestri G
    J Virol; 2015 Sep; 89(17):8677-86. PubMed ID: 26063417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between Mycobacterium leprae and simian immunodeficiency virus (SIV) in rhesus monkeys.
    Gormus BJ; Murphey-Corb M; Baskin GB; Uherka K; Martin LN; Marx PA; Xu K; Ratterree MS
    J Med Primatol; 2000 Aug; 29(3-4):259-67. PubMed ID: 11085588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of plasma viremia and antibody responses in macaques inoculated with envelope variants of single-cycle simian immunodeficiency virus differing in infectivity and cellular tropism.
    DeGottardi MQ; Lew SK; Piatak M; Jia B; Feng Y; Lee SJ; Brenchley JM; Douek DC; Kodama T; Lifson JD; Evans DT
    J Virol; 2008 Jan; 82(1):321-34. PubMed ID: 17942538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia.
    Brocca-Cofano E; McKinnon K; Demberg T; Venzon D; Hidajat R; Xiao P; Daltabuit-Test M; Patterson LJ; Robert-Guroff M
    Vaccine; 2011 Apr; 29(17):3310-9. PubMed ID: 21382487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-infection immunodeficiency virus control by neutralizing antibodies.
    Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    PLoS One; 2007 Jun; 2(6):e540. PubMed ID: 17579714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies.
    Jaspan HB; Robinson JE; Amedee AM; Van Dyke RB; Garry RF
    J Clin Virol; 2004 Nov; 31(3):190-7. PubMed ID: 15465411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction.
    Brocca-Cofano E; Kuhrt D; Siewe B; Xu C; Haret-Richter GS; Craigo J; Labranche C; Montefiori DC; Landay A; Apetrei C; Pandrea I
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animals.
    Greenier JL; Van Rompay KK; Montefiori D; Earl P; Moss B; Marthas ML
    Virol J; 2005 Feb; 2():11. PubMed ID: 15710048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.